Gregory Piazza, Sean Pokorney, Charles Pollack, Jr.

Gregory Piazza, MD (Activity Chair)

Assistant Professor of Medicine
Harvard Medical School
Associate Physician
Brigham and Women's Hospital
Cardiovascular Medicine
Boston, Massachusetts

Dr. Piazza is an Assistant Professor of Medicine at Harvard Medical School and is faculty in the Cardiovascular Division at Brigham and Women's Hospital in Boston, Massachusetts. Dr. Piazza received his Medical Degree from the University of Massachusetts Medical School in Worcester, Massachusetts. He completed his residency in Internal Medicine, served as the chief medical resident, and completed Fellowships in General Cardiology and Advanced Cardiovascular Imaging at the Beth Israel Deaconess Medical Center in Boston, Massachusetts. He also completed a National Heart, Lung, and Blood Institute–sponsored Advanced Fellowship in Vascular Medicine at Brigham and Women’s Hospital. Dr. Piazza’s research interests include the epidemiology, pathophysiology, diagnosis, treatment, and prevention of venous thromboembolism, thrombophilia-associated infertility, computerized decision support to improve cardiovascular outcomes, and stroke prevention in atrial fibrillation.

Back to top

Sean Pokorney, MD

Assistant Professor of Medicine
Duke University
Durham, North Carolina

Dr. Pokorney is an Electrophysiologist and Assistant Professor of Medicine at Duke University in Durham, North Carolina. His areas of expertise include treatment options related to stroke prevention in atrial fibrillation, bleeding management in atrial fibrillation, atrial fibrillation prevention and rhythm management, contact force-sensing catheters, the use of antiarrhythmic medications, risk of sudden death and use of implantable cardioverter-defibrillators after acute cardiovascular events, and lead management for patients with cardiac implantable electronic devices.

He received his MD and his MBA in Health Industry Management from Northwestern University in Evanston, Illinois. His post-graduate training included a Clinical Research Fellowship at the Duke Clinical Research Institute, as well as a Cardiovascular Disease Fellowship and an Electrophysiology Fellowship at the Duke University Medical Center.

Dr. Pokorney has contributed book chapters on pharmacological management of atrial fibrillation in the outpatient setting and on managing recurrent implanted cardioverter defibrillator (ICD) therapies. He has also presented on the Food and Drug Administration’s restriction of edoxaban use in atrial fibrillation patients with normal renal function and on the low rates of ICD use among Medicare patients with low ejection fraction after acute myocardial infarction.

Dr. Pokorney’s research has been published in peer-reviewed journals such as the JAMA, Lancet, Circulation, Journal of the American College of Cardiology, Heart Rhythm, JACC Electrophysiology, Circulation Arrhythmia and Electrophysiology, American Heart Journal, American Journal of Cardiology, and Journal of the American Heart Association.

Back to top

Charles Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP

Associate Provost for Innovation in Education, Thomas Jefferson University
Director, Jefferson Institute of Emerging Health Professions
Department of Emergency Medicine
Sidney Kimmel Medical College of Thomas Jefferson University
Philadelphia, Pennsylvania

In 2015, Dr. Pollack assumed multiple roles at Thomas Jefferson University in Philadelphia, Pennsylvania including Associate Provost for Innovation in Education, Thomas Jefferson University; Director, Jefferson Institute of Emerging Health Professions; Associate Dean for CME and Strategic Partner Alliances, Thomas Jefferson University; and, Professor and Senior Advisor for Interdisciplinary Research and Clinical Trials, Department of Emergency Medicine, Sidney Kimmel Medical College of Thomas Jefferson University.

From 2001-2015, Dr. Pollack was Professor of Emergency Medicine at the Perelman School of Medicine of the University of Pennsylvania and served as Chairman of Emergency Medicine at Pennsylvania Hospital in Philadelphia. From 1992-2001, Dr. Pollack served in various positions in the Department of Emergency Medicine at Maricopa Medical Center in Phoenix, Arizona, an urban, tertiary care teaching hospital affiliated with the Medical College of the University of Arizona and the Mayo Graduate School of Medicine. He was Research Director from 1994 to 2000, and he chaired the department from 1997 to 2001. From 2000 through mid-2001, Dr. Pollack was also Director of Emergency Medicine at Arizona Heart Hospital. He graduated summa cum laude from Emory University in 1980 with Bachelor’s Degrees in History and Chemistry and with a Master’s Degree in The History of Science and Medicine and was elected to Phi Beta Kappa. Dr. Pollack earned his Medical Degree from Tulane University School of Medicine and is a member of Alpha Omega Alpha.

Dr. Pollack has long been active in teaching and clinical research and is an international leader in emergency medicine. He is the only physician to have received the American College of Emergency Physicians’ highest national awards in both teaching and research; he also received the national teaching award from the Council of Emergency Medicine Residency Directors. He is the only US emergency physician to be elected a Fellow of the European Society of Cardiology. His primary research interests are in the management of thrombosis, both arterial (especially acute coronary syndrome) and venous (deep venous thrombosis and pulmonary embolism), reversal of anticoagulation, infectious disease emergencies, and treatment of pain.

Dr. Pollack leads The Lambert Center for the Study of Medicinal Cannabis and Hemp at Thomas Jefferson University. The Center, which he founded in May 2016, is the only comprehensive academic resource for education, research, and practice around the use of medicinal cannabinoids to be housed in a US health sciences university.

Dr. Pollack has written more than 500 original research articles, chapters, and abstracts, and serves on the editorial boards of several journals and on the steering committees of multiple national and international trials. He is the Principal Investigator on multiple ongoing trials, studies, and registries. Dr. Pollack also lectures widely on many varied topics in emergency medicine. He is a strong advocate for entrepreneurism and innovation in healthcare and is involved in multiple telehealth initiatives. He is a founding Board member of the Hospital Quality Foundation, a not-for-profit education and research organization dedicated to improvement in the quality of care provided to patients in the hospital and at transition back to the outpatient setting.

Back to top